“Cures AHEAD” Golf Invitational Raises Over $120,000 to Benefit The Gateway for Cancer Research

The Gateway for Cancer ResearchKaren Kay, (847) 342-6477

Two organizations with a shared goal of supporting cancer research came together this past week to host the first annual “Cures AHEAD” Golf Invitational with impressive results. The event exceeded organizers’ expectations, raising $120,595 to benefit The Gateway for Cancer Research().

The golf invitational was conceived as result of a close working relationship between AHEAD and the Cancer Treatment Centers of America (CTCA) Information Technology department. CTCA IT uses technology to improve the quality of patient care from first contact to completion of treatment and AHEAD assists CTCA in this critical endeavor. Wanting to take the partnership and their support of cancer patients to the next level by also supporting cancer research, AHEAD started the annual outing.

“Cures AHEAD” was held at The Glen Club in Glenview, recognized as one of the best courses in Chicagoland. Participants enjoyed a wonderful day of golf, great raffle prizes that included a golf package at The Breakers Palm Beach, Cubs Tickets, and a foursome at The Glen Club; and a terrific silent auction that featured items such as an iPad 2, Joakim Noah autographed basketball, Brett Favre and Brian Urlacher autographed framed photos, and tickets to the 2012 Ryder Cup at Medinah Country Club.

Nearly 100 golfers representing 28 companies participated in the golf invitational. Among the many generous donors and sponsors were AHEAD and Cisco, who each donated $15,000. AHEAD and CTCA IT made the tremendous turnout and results possible by reaching out to their own IT communities and networks, all of whom were ready and willing to support the cause.

Proceeds from the event will be donated to The Gateway for Cancer Research, a nonprofit organization that funds innovative cancer research focused on helping cancer patients feel better, live longer and be cured today. The Gateway supports both conventional and complementary and alternative medicine (CAM) therapies, including novel drug combinations and new drug investigations with the aim of speeding treatment options to the bedside to save lives.

“We are very grateful to be the beneficiary of a wonderful event that brought people together from so many companies to help improve the outcome for cancer patients,” said Lynette Bisconti, President of The Gateway for Cancer Research. “Support from events like “Cures AHEAD” helps make it possible for us to fund research that can lead to lifesaving treatments and cures for today’s cancer patients.” 99 cents of every dollar The Gateway receives goes to fund cancer research.

For more information about Gateway-funded clinical trials, visit: , or to see how you can help make a difference in the fight against cancer, visit .

The Gateway for Cancer Research is a non-profit organization committed to funding innovative research and bold new ideas for lifesaving treatments. We’re demanding cures to improve and save the lives of today’s patients, now. Our mission is to fund clinical research to speed breakthroughs to the bedside to help cancer patients live longer, feel better and be cured today.” Since our founding in 1991, The Gateway has funded $20 million in leading-edge research, including blending the best of conventional and complementary/alternative therapies. Follow us on [email protected] and become a fan at .

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.